GI & Endoscopy

Here are five gastroenterologists who recently made headlines.

Osaka, Japan-based Takeda Pharmaceutical and Los Altos, Calif.-based Altos Therapeutics are teaming up to develop Altos' proprietary compound to treat gastroparesis, according to Yahoo! Finance.

Thomas J. McGarrity, MD, is chief of gastroenterology and hepatology at the Penn State Milton S. Hershey Medical Center.

The American Gastroenterological Association participated in a roundtable discussion with CMS.

A study, published in The American Journal of Gastroenterology, examined trends in anesthesia service use during outpatient gastroenterology procedures.

Specializing in hepatology and gastroenterology, Jeffrey Dunkelberg, MD, PhD, practices at the University of Iowa in Iowa City. He also has expertise in treating hepatomas and hepatitis.

Vancouver, Canada-based CRH Medical acquired a 51 percent stake in Arapahoe Gastroenterology Anesthesia Associates.

Researchers with United European Gastroenterology have discovered physicians sometimes misdiagnose inflammatory bowel disease patients with irritable bowel syndrome, according to Bel Marra Health.

Michael Camilleri, MD, is a professor of medicine at the Mayo Medical School in Rochester, Minn. He previously served as president-elect of the American Gastroenterological Association between 2014 and 2015.

Here are six recent news updates on key gastroenterology and endoscopy companies.